Last updated on April 16, 2014 at 17:34 EDT

Latest Zinc finger chimera Stories

2012-10-17 07:26:15

RICHMOND, Calif., Oct. 17, 2012 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced that data from its program with Shire AG (LSE: SHP, NASDAQ: SHPG) to develop a novel ZFP Therapeutic approach to Huntington's disease (HD), an inherited progressive neurodegenerative disease, were presented at the 2012 Annual Meeting of the Society for Neuroscience, which is the world's largest forum for neuroscientists and is being held in New Orleans from October 13-17, 2012. The data...